Hope For Hepatitis C Patients
Newly approved drugs could revolutionize treatment.
A new class of drugs could revolutionize the lives of Hepatitis C patients, nearly doubling the chance of a cure and, for many cutting treatment time in half.
Just approved by the FDA, the drugs short circuit the ability of the Hepatitis C virus to replicate, akin to the strategy used to combat HIV.
They're made by rivals Merck and biotech Vertex, and are expected to carry a hefty price tag.